Editorial: New strategies for the treatment of advanced melanoma and non-melanoma skin cancer by Alessia Villani, Luca Potestio, Aimilios Lallas

Get full text

Letter to the editor submitted in response to ‘Should the presence of psoriatic arthritis change how we manage psoriasis?’ by Matteo Megna, Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini, Luca Potestio

Get full text

The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life study by Sara Cacciapuoti, Matteo Megna, Emanuela Salza, Luca Potestio, Giuseppina Caiazzo

Get full text

Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study by Matteo Megna, Luca Potestio, Angelo Ruggiero, Elisa Camela, Gabriella Fabbrocini

Get full text

Letter to the editor submitted in response to ‘Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study’ by Maddalena Napolitano, Luca Potestio, Francesca Di Vico, Gabriella Fabbrocini, Cataldo Patruno

Get full text

The Treatment of Advanced Melanoma: Therapeutic Update by Alessia Villani, Luca Potestio, Gabriella Fabbrocini, Giancarlo Troncone, Umberto Malapelle, Massimiliano Scalvenzi

Get full text

Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study by Matteo Megna, Angelo Ruggiero, Teresa Battista, Laura Marano, Sara Cacciapuoti, Luca Potestio

Get full text

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area by Alessia Villani, Gabriella Fabbrocini, Giuseppe Micali, Luigi Fornaro, Luca Potestio, Massimiliano Scalvenzi

Get full text

Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. <i>J. Clin. Med.</i> 2022... by Luca Potestio, Luigi Fornaro, Fabrizio Martora, Vincenzo Picone, Gabriella Fabbrocini, Claudio Marasca

Get full text

Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature by Fabrizio Martora, Massimiliano Scalvenzi, Angelo Ruggiero, Luca Potestio, Teresa Battista, Matteo Megna

Get full text

The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature by Fabrizio Martora, Teresa Battista, Angelo Ruggiero, Massimiliano Scalvenzi, Alessia Villani, Matteo Megna, Luca Potestio

Get full text

Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? by Fabrizio Martora, Gabriella Fabbrocini, Matteo Megna, Massimiliano Scalvenzi, Teresa Battista, Alessia Villani, Luca Potestio

Get full text

Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study by Teresa Battista, Lucia Gallo, Fabrizio Martora, Davide Fattore, Luca Potestio, Sara Cacciapuoti, Massimiliano Scalvenzi, Matteo Megna

Get full text

Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study by Matteo Megna, Nello Tommasino, Luca Potestio, Teresa Battista, Angelo Ruggiero, Matteo Noto, Gabriella Fabbrocini, Lucia Genco

Get full text

Dupilumab for the treatment of adult atopic dermatitis in special populations by Cataldo Patruno, Luca Potestio, Massimiliano Scalvenzi, Teresa Battista, Flavia Raia, Vincenzo Picone, Gabriella Fabbrocini, Maddalena Napolitano

Get full text

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge by Luca Potestio, Teresa Battista, Sara Cacciapuoti, Angelo Ruggiero, Fabrizio Martora, Luigi Fornaro, Elisa Camela, Matteo Megna

Get full text

New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge? by Matteo Megna, Sonia Sofia Ocampo-Garza, Luca Potestio, Giuseppina Fontanella, Lucia Gallo, Sara Cacciapuoti, Angelo Ruggiero, Gabriella Fabbrocini

Get full text

Guselkumab-induced vitiligo in a patient with psoriatic arthritis by Fabrizio Martora, MD, Maria Carmela Annunziata, MD, Luigi Guerriero, MD, Teresa Battista, MD, Luca Potestio, MD, Matteo Megna, MD

Get full text

Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire by Elisa Camela, Alessia Villani, Sonia Sofia Ocampo Garza, Claudia Costa, Gabriella Fabbrocini, Matteo Megna, Luca Potestio, Angelo Ruggiero, Massimiliano Scalvenzi

Get full text

Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications by Claudio Marasca, Maria Carmela Annunziata, Elisa Camela, Adriana Di Guida, Luigi Fornaro, Matteo Megna, Maddalena Napolitano, Cataldo Patruno, Luca Potestio, Gabriella Fabbrocini

Get full text